The “Credit Card Competition Act” introduced by Sen. Durbin (D-IL) this past summer aims to give the Federal Reserve the power to control how payments on credit cards are routed.
Language in this year’s defense authorization bill that would bar the government from continuing to do business with genomics companies with ties to China has sparked a lobbying fight.
“This is an issue of Main Street versus Wall Street,” Marshall said. “Wall Street is capitalizing to the tune of $90 billion a year. So we want some of that money to go back home.”